Liangmin Fu

9PUBLICATIONS
48CO-AUTHORS
Cancer diagnosisMolecular targetsMechanobiologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 03, 2026
TFE3-DualNet: An Interpretable Foundation Model-Based Deep Learning Ensemble for Diagnosing TFE3-Rearranged Renal Cell Carcinoma From Whole-Slide Images in a Two-Center Cohort.

|Feb 12, 2026
Targeting the C/EBPβ-PRAME-EZH2 complex modulates the Netrin-4/AKT axis to inhibit renal cancer tumorigenesis and metastasis.

Li-Zhen Zhang, Zheng-Kun Zhang, Liang-Min Fu

|Sep 15, 2025
TWF2 Drives Tumor Progression and Sunitinib Resistance in Renal Cell Carcinoma through Hippo Signaling Suppression.

Liangmin Fu, Wuyuan Liao, Youyan Tan

|Feb 23, 2025
STX17-DT facilitates axitinib resistance in renal cell carcinoma by inhibiting mitochondrial ROS accumulation and ferroptosis.

Yihui Pan, Shuang Liu, Guannan Shu

|Dec 13, 2024
Methionine-driven YTHDF1 expression facilitates bladder cancer progression by attenuating RIG-I-modulated immune responses and enhancing the eIF5B-PD-L1 axis.

Anze Yu, Liangmin Fu, Lanyu Jing

|Feb 24, 2024
Pan-Cancer Analysis Reveals Disulfidoptosis-Associated Genes as Promising Immunotherapeutic Targets: Insights Gained from Bulk Omics and Single-Cell Sequencing Validation.

Borui Xu, Minghao Li, Nuoqing Weng

Pageof 2

Frequent Collaborators

4 joint publications

Zhenhua Chen

4 joint publications

Junhang Luo

3 joint publications

Yinghan Wang

2 joint publications

Jiangquan Zhu